Additional file 1 of Design, synthesis, and molecular dynamics simulation studies of some novel kojic acid fused 2-amino-3-cyano-4H-pyran derivatives as tyrosinase inhibitors
Creators: name: Najafi, Zahra
name: Zandi Haramabadi, Maryam
name: Chehardoli, Gholamabbas
name: Ebadi‬, Ahmad
name: Iraji, Aida
Publisher: name: figshare
Year: 2024
Subjects: subject: Biochemistry
subject: Medicine
subject: Genetics
subject: FOS: Biological sciences
subject: Neuroscience
subject: Pharmacology
subject: Biotechnology
subject: Chemical Sciences not elsewhere classified
subject: Biological Sciences not elsewhere classified
subject: Information Systems not elsewhere classified
subject: Infectious Diseases
subject: FOS: Health sciences
subject: Virology

description: Additional file 1: Fig. S1. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-(benzyloxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano [3,2-b] pyran-3-carbonitrile (6a). Fig. S2. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-fluorobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6b). Fig. S3. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-chlorobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6c). Fig. S4. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-boromobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8 dihydropyrano[3,2-b]pyran-3-carbonitrile (6d). Fig. S5. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-6-(hydroxymethyl)-4-(4-((4-methylbenzyl)oxy)phenyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6e). Fig. S6. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(3-(benzyloxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6f). Fig. S7. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(3-((4-fluorobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6g). Fig. S8. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(3-((4-chlorobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6h). Fig. S9. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(3-((4-boromobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6i), Fig. S10. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(3-((4-boromobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6j). Fig. S11. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-(benzyloxy)-3-methoxyphenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6k), Fig. S12. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-fluorobenzyl)oxy)-3-methoxyphenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6l), Fig. S13. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-cholorobenzyl)oxy)-3-methoxyphenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6m). Fig. S14. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-4-(4-((4-boromobenzyl)oxy)-3-methoxyphenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2-b]pyran-3-carbonitrile (6n). Fig. S15. FT-IR, 1H NMR and 13C NMR spectrums of 2-amino-6-(hydroxymethyl)-4-(3-methoxy-4-((4-methylbenzyl)oxy)phenyl)-8-oxo-4,8 dihydropyrano[3,2-b]pyran-3-carbonitrile (6o).